A Phase II Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Refractory to Taxane Regimens
Phase of Trial: Phase II
Latest Information Update: 29 Sep 2005
At a glance
- Drugs ABT 751 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 29 Sep 2005 New trial record.